Adam N. Rosenthal
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment 31
- Obstetrics and Gynecology top 1%
- Endometrial and Cervical Cancer Treatments 12
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 6
- Cancer-related molecular mechanisms research 6
- Genetics top 5%
- BRCA gene mutations in cancer 14
- Oncology top 5%
-
- Cervical Cancer and HPV Research 21
-
- Colorectal and Anal Carcinomas 9
-
- Reproductive Biology and Fertility 5
Adam N. Rosenthal
63 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 107
- Reproductive Medicine 1.0k
- Obstetrics and Gynecology 513
- Cancer Research 320
- Genetics 519
- Oncology 501
Countries citing papers authored by Adam N. Rosenthal
This map shows the geographic impact of Adam N. Rosenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam N. Rosenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam N. Rosenthal more than expected).
Fields of papers citing papers by Adam N. Rosenthal
This network shows the impact of papers produced by Adam N. Rosenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam N. Rosenthal. The network helps show where Adam N. Rosenthal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adam N. Rosenthal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 7 | |
| 6 | 2018 | 12 | |
| 7 | 2015 | 79 | |
| 8 | 2014 | 61 | |
| 9 | RESULTS OF INTENSIVE ALGORITHM-BASED SCREENING IN THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UK FOCSS PHASE 2) | 2013 | 1 |
| 10 | 2013 | 10 | |
| 11 | 2013 | 12 | |
| 12 | 2012 | 58 | |
| 13 | 2012 | 15 | |
| 14 | 2011 | 12 | |
| 15 | 2002 | 34 | |
| 16 | 2001 | 54 | |
| 17 | p53 codon 72 polymorphism and the risk of cervical cancer in UK Caucasians (abstract) | 1999 | 1 |
| 18 | 1999 | 383 | |
| 19 | 1999 | 50 | |
| 20 | 1998 | 79 |
About Adam N. Rosenthal
Adam N. Rosenthal is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Cancer Research, having authored 69 papers that have together received 2.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (31 papers), Cervical Cancer and HPV Research (21 papers), BRCA gene mutations in cancer (14 papers), Endometrial and Cervical Cancer Treatments (12 papers), Colorectal and Anal Carcinomas (9 papers), Cancer Genomics and Diagnostics (6 papers), Cancer-related molecular mechanisms research (6 papers) and Reproductive Biology and Fertility (5 papers). The work is most often cited by research in Reproductive Medicine (1.0k citations), Obstetrics and Gynecology (513 citations) and Cancer Research (320 citations). Adam N. Rosenthal has collaborated with scholars based in United Kingdom, United States and Egypt. Frequent co-authors include Ian Jacobs, Usha Menon, Nicola MacDonald, Steven J. Skates, Karen Sibley, Arjun Jeyarajah, David Oram, Sara Paterson‐Brown, Ann Prys Davies and David Lowe. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.